ArticleInternational journal of molecular sciences2022

The Novel Class IIa Selective Histone Deacetylase Inhibitor YAK540 Is Synergistic with Bortezomib in Leukemia Cell Lines.

Lukas M Bollmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.